Skip to content
10-Q

Quarterly Report

TriVascular Technologies, Inc.

0001564590-14-005459

← back to feed
Filed
Nov 12, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Oct 31, 2014 20.37M sh
Stockholders Equity Q3 2014 · Sep 30, 2014 $52.47M
Stockholders Equity Q3 2014 · Dec 31, 2013 −$228.8M
Current Liabilities Q3 2014 · Sep 30, 2014 $8.8M
Current Liabilities Q3 2014 · Dec 31, 2013 $7.81M
Total Liabilities Q3 2014 · Sep 30, 2014 $57.2M
Total Liabilities Q3 2014 · Dec 31, 2013 $53.51M
Current Assets Q3 2014 · Sep 30, 2014 $98.21M
Current Assets Q3 2014 · Dec 31, 2013 $52.33M
Total Assets Q3 2014 · Sep 30, 2014 $109.67M
Total Assets Q3 2014 · Dec 31, 2013 $64.7M
Capex Q3 2014 · Sep 30, 2013 $202K
Cash And Equivalents Q3 2014 · Sep 30, 2013 $10.86M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $45.39M
Sga Expense Q3 2014 · Sep 30, 2013 $9.86M
Sga Expense Q3 2014 · Sep 30, 2013 $27.06M
Rd Expense Q3 2014 · Sep 30, 2013 $3.28M
Rd Expense Q3 2014 · Sep 30, 2013 $9.59M
Net Income Q3 2014 · Sep 30, 2013 −$12.7M
Net Income Q3 2014 · Sep 30, 2013 −$36.82M
Operating Income Q3 2014 · Sep 30, 2013 −$11.22M
Operating Income Q3 2014 · Sep 30, 2013 −$32.11M
Gross Profit Q3 2014 · Sep 30, 2013 $1.92M
Gross Profit Q3 2014 · Sep 30, 2013 $4.54M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $3.59M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $8.74M